JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  2006

ACB-CLIN-CHEM-GEN 2006

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Quantities and properties

From:

Mike Toop <[log in to unmask]>

Reply-To:

Mike Toop <[log in to unmask]>

Date:

Thu, 23 Nov 2006 23:40:01 -0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (213 lines)

It seems therefore that there are very few absolutes. As most things are
relative and poorly understood perhaps we need some degree of pragmatism and
incomplete models to make progress. If the model is simple and works most of
the time use it and accept these imperfections. Everything is as work in
progress. You get 80% of the benefit for 20% of the work.
Hope your inspection goes well.
mike


-----Original Message-----
From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Jonathan G. Middle
Sent: 23 November 2006 13:51
To: [log in to unmask]
Subject: FW: Quantities and properties

 
Taking a break from preparing for our CPA EQA inspection!!


Definitions of 'analyte' on the web
===================================

# the substance which a laboratory test aims to detect. In cholesterol
testing, for example, the analyte is cholesterol. In genetic testing, the
analyte could be, for example, a specific allele or genetic mutation.
www.cs.uu.nl/people/ronnie/local/genome/a.html

# (an·a·lyte) (an˘[schwa]-l[imacr]t) a substance undergoing analysis.
www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspzQzpgzEzzSzppdocszSzuszSzco
mmonzSzdorlandszSzdorlandzSzdmd_a_34zPzhtm

# A substance measured in the laboratory. A chemical for which a sample
(such as water, air, or blood) is tested in a laboratory. For example, if
the analyte is mercury, the laboratory test will determine the amount of
mercury in the sample (ATSDR 2003).
www.racteam.com/LANLRisk/Glossary.htm

# Identifies the analyte that was measured. See Analyte Categories With
Associated Analytes for association between analyte category and analyte.
www.cropcomposition.org/databaseorg/Glossary%20of%20Terms.htm

# The substance measured by a laboratory test; for instance, a specific
mutation or allele.
www.cdc.gov/genomics/gtesting/ACCE/FBR/CF/CFGlossary2.htm

# Substance to be measured.
ojjdp.ncjrs.org/PUBS/drugid/glossary.html

# A name given to describe a substance which is being produced in an
analytical procedure.
www.pestmanagement.co.uk/lib/glossary/glossary_a.shtml

# A chemical being tested for in a laboratory test.
www.rrmsc.com/resources/glossary.htm

# An Analyte is the substance or chemical constituent that is undergoing
analysis. The substance being measured in an analytical procedure.
en.wikipedia.org/wiki/Analyte

======================

The common theme seems to be 'a substance that is measured/analysed in a
laboratory'.  
I fear we may get into more arguments if we come to define 'substance',
'measure' or 'laboratory!

I can't make any statements about the physical world because this may just
be a construct of my consciousness, which may itself just be an emergent
property of brain complexity!

======================

To be constructive though, is this all about naming things?  We use the
scientific process to refine our knowledge of the components of the natural
world and in clinical biochemistry we concentrate on the components of
biological systems, especially those that help us understand health and
disease.  We observe, separate out, analyse, purify, characterise things and
give them names.  By doing so we actually bring those things into existence
in our 'universe of discourse' so that we can refine techniques to study
them and ultimately measure them for the good of patients.  Some things are
physical entities which we can separate out and name and others are
attributes (I hesitate to call them properties!) because we don’t know
enough about what generates what we observe.

Some things are easy to name and are truly unique - elements, simple
compounds etc.  Others are more difficult - proteins etc - which are
heterogeneous and exist in multiple forms in health and disease.  In respect
of the latter we end up with names of things that imply uniqueness (to us
and our customers) but the reality is different.  JCTLM classify 'analytes'
as type 1 (the easy ones as above) and type 2 (the difficult ill-defined
ones)  

The ordinary man in the street would naturally assume that if we say we are
measuring analyte X in his blood, then analyte X must exist and we must know
exactly what analyte X is otherwise we can't possibly measure it.  I try to
understand what Roger and Anders are saying but I could not possibly explain
their detailed metrological philosophy to a patient (or a doctor).
Enjoyable as this discussion has been we cannot escape the fact that we have
to agree amongst ourselves what we do and then communicate this to a lay
public.  So in Mike's real world of 'consensus reality' where we have to
demonstrate and prove to our customers and paymasters that what we do adds
value to the clinical event, we must be sure in our own minds what we mean
by these words.  

As a starting point for discussion, might we agree on the following working
‘common sense’ concepts for the 'things' that we list in our test
repertoire:

Type 1 component - an entity which is uniquely named, chemically defined,
exists in the same form wherever it is encountered, where a standard exists
which can calibrate measurement procedures, and where results can be
expressed in method-independent SI units of mass or molar amount - eg
Cortisol

Type 2 component - a group of closely related entities which share structure
and function and thus may be named under a single heading, which can be
purified and characterised to some extent, but without certain knowledge
that these entities are the same in the standard material as are in the
patient, and where results are expressed in arbitrary units which are
method-dependent - eg TSH

Attribute - an observed characteristic of a sample which can be quantitated
in arbitrary unitage in a defined system - eg ‘ischaemia modified albumin’
(serum cobalt binding)

These are all analytes (probably) but we have to think about them in
different ways when we discuss and assess comparability, trueness,
uncertainty, standardisation and traceability and when we communicate to our
users on their meaning and significance.

My assertions:

Type 1 component - absolutely no option but to achieve common
standardisation and harmonised results using established reference
measurement systems with true metrological traceability

Type 2 component - the way forward for many of these is exemplified in the
approach taken by the the ISOBM TD-7 Workshop on hCG and related molecules :
Berger et al. Towards user-oriented standardization of pregnancy and tumor
diagnosis: assignment of epitopes to the three-dimensional structure of
diagnostically and commercially relevant monoclonal antibodies directed
against human chorionic gonadotropin and derivatives. Tumour Biol. 2002
Jan-Feb;23(1):1-38.

Attribute - more hard scientific work to sort out what is going on before we
make claims about what is being measured and how useful it is.    

Sorry if this is repeating myself and maybe stating the obvious!

Hope this is helpful

J

Back to the Quality Management System now!


Dr Jonathan Middle
Deputy Director, UK NEQAS Birmingham
0121 414 7300, fax 0121 414 1179
-----------------------------------------------
All opinions expressed in this email are mine alone and are not necessarily
representative of the views of the UK NEQAS organisation, UK NEQAS
Birmingham (Wolfson EQA Laboratory), University Hospital Birmingham NHS
Foundation Trust or University of Birmingham.



-----Original Message-----
From: Clinical biochemistry discussion list on behalf of Mike Toop
Sent: Wed 22/11/2006 19:58
To: [log in to unmask]
Subject: Re: Quantities and properties
 
Pedantry is a great spectator sport!

Here is my (brief ) 5 pence worth

What do we mean by analyte and how does that definition relate to the
physical world?

 

Mike 

 

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager